EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture

Major Extremity Trauma Research Consortium (METRC), Robert V O'Toole, Deborah M Stein, Nathan N O'Hara, Katherine P Frey, Tara J Taylor, Daniel O Scharfstein, Anthony R Carlini, Kuladeep Sudini, Yasmin Degani, Gerard P Slobogean, Elliott R Haut iD und 6 weitere

New England Journal of Medicine · 19.01.2023 · 388 (3) · 203-213

DOI: 10.1056/nejmoa2205973 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift New England Journal of Medicine, erschienen am 19.01.2023. Verfasst von Major Extremity Trauma Research Consortium (METRC) und 17 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Orthopedics (R.V.O., N.N.O., Y.D., G.P.S.) and Surgery (D.M.S.), R Adams Cowley Shock Trauma Center, the University of Maryla…. Hauptthemen laut MEDLINE: Anticoagulants, Aspirin, Chemoprevention, Fractures, Bone. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAspirinChemopreventionFractures, BoneHeparin, Low-Molecular-WeightAdultHumansMiddle AgedExtremitiesHemorrhageHip FracturesPelvic BonesPragmatic Clinical Trials as TopicPulmonary EmbolismSpinal FracturesVenous ThromboembolismVenous Thrombosis

Substanzen

AnticoagulantsAspirinHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • From the Departments of Orthopedics (R.V.O., N.N.O., Y.D., G.P.S.) and Surgery (D.M.S.), R Adams Cowley Shock Trauma Center, the University of Maryland School of Medicine, Department of Health Policy and Management, Joh…

ORCID-Profile: Elliott R Haut

Förderung

  • Patient-Centered Outcomes Research Institute

Zitieren

APA

Major Extremity Trauma Research Consortium (METRC), O'Toole, R. V., Stein, D. M., O'Hara, N. N., Frey, K. P., Taylor, T. J., Scharfstein, D. O., Carlini, A. R., Sudini, K., Degani, Y., Slobogean, G. P., Haut, E. R., Obremskey, W., Firoozabadi, R., Bosse, M. J., Goldhaber, S. Z., Marvel, D., & Castillo, R. C. (2023). Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. New England Journal of Medicine, 388(3), 203-213. https://doi.org/10.1056/nejmoa2205973

Vancouver

Major Extremity Trauma Research Consortium (METRC), O'Toole RV, Stein DM, O'Hara NN, Frey KP, Taylor TJ, et al. Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. New England Journal of Medicine. 2023;388(3):203-213. doi:10.1056/nejmoa2205973

BibTeX
@article{MajorExtremityTraumaResearchConsortiumMETRC2023,
  author = {Major Extremity Trauma Research Consortium (METRC), Major Extremity Trauma Research Consortium (METRC) and O'Toole, Robert V and Stein, Deborah M and O'Hara, Nathan N and Frey, Katherine P and Taylor, Tara J and Scharfstein, Daniel O and Carlini, Anthony R and Sudini, Kuladeep and Degani, Yasmin and Slobogean, Gerard P and Haut, Elliott R and Obremskey, William and Firoozabadi, Reza and Bosse, Michael J and Goldhaber, Samuel Z and Marvel, Debra and Castillo, Renan C},
  title = {Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {3},
  pages = {203--213},
  doi = {10.1056/nejmoa2205973}
}
Kostenlos starten →